2006 Oct 13.

Establishing risk of human experimentation with drugs: lessons from TGN1412.

CHDR

Kenter MJ, Cohen AF

More related publications

Implications of the BIA-102474-101 study for review of first-into-human clinical trials.

Eddleston M, Cohen AF, Webb DJ, 2016 Mar 31

View publication
Towards a sustainable system of drug development.

Moors EH, Cohen AF, Schellekens H, 2014 Oct 31

View publication
Vanishing clinical psychopharmacology.

van Gerven J, Cohen A, 2011 Jun 30

View publication

Careers
News
Contact
Search

Clinical studies & Development
CHDR's story
People
Education
Library

Clinical development & Services

Therapeutic areas
Central Nervous System
Immunology & Inflammation
Cardiovascular & Metabolic disease
Internal Medicine
Methods & Biomarkers
Central Nervous System
Translational Biomarkers
Immunology & Inflammation
Cardiovascular & Metabolic disease
- Metabolic and endocrine responses
- Cardiac and endovascular function assessments
Imaging Techniques
Trial Services
Participate in a Clinical Trial proefpersoon.nl

Browse 1137 publications in the CHDR library

Clinical studies & Development
CHDR's story
People
Education
Library

Clinical development & Services

Therapeutic areas
Central Nervous System
Immunology & Inflammation
Cardiovascular & Metabolic disease
Internal Medicine
Methods & Biomarkers
Central Nervous System
Translational Biomarkers
Immunology & Inflammation
Cardiovascular & Metabolic disease
- Metabolic and endocrine responses
- Cardiac and endovascular function assessments
Imaging Techniques
Trial Services
Participate in a Clinical Trial proefpersoon.nl

Browse 1137 publications in the CHDR library

Partners

Sponsors
Collaborations

People

Supervisory board
Scientific advisory board
Governance

Social media

Twitter
LinkedIn

Privacy policy
Whistleblowers regulation

Website by Just